Discounting in economic evaluation of health care interventions: what about the risk term?

European Journal of Health Economics

13 March 2021 - Results from economic evaluations of long-term outcomes are strongly dependent on the chosen discount rate. 

A recent review of national guidelines for evaluation of healthcare interventions finds that “the level of currently used discount rates seems relatively high in many countries”. 

However, this conclusion comes from a comparison to rates derived or observed for investments in safe assets, while rate of return requirements are typically considerably higher when investment involves risk.

Read European Journal of Health Economics article

Michael Wonder

Posted by:

Michael Wonder